Alkermes Plc (NASDAQ:ALKS)

During the Trading Day
70.80 -2.00 / -2.75%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
70.94 +0.14 / +0.20%
Volume: 44.1K
Health Technology

Company Description

Alkermes Plc is a biopharmaceutical company, which engages in the development, manufacturing and distribution of medicines. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system disorders such as addiction, schizophrenia and depression. Alkermes was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Alkermes Plc
Connaught House
Dublin Dublin 4
P:(531) 772-8000
Investor Relations:



Mutual fund holders75.49%
Other institutional23.71%
Individual stakeholders0.79%

Top Executives

Richard F. PopsChairman & Chief Executive Officer
Shane M. CookePresident
Gordon G. PughSenior VP, Chief Operating & Risk Officer
James M. FratesChief Financial Officer, Treasurer & Senior VP
Elliot W. EhrichChief Medical Officer, SVP-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account